Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schoppet

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|November 15, 2002
Osteoprotegerin deficiency and juvenile Paget's diseaseLorenz C Hofbauer, Michael Schoppet
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular diseaseLorenz C Hofbauer, Michael Schoppet
JAMA|July 29, 2004
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseasesLorenz C Hofbauer, Michael Schoppet
Archives of Pathology & Laboratory Medicine|January 11, 2003
CD83+ dendritic cells in inflammatory infiltrates of Churg-Strauss myocarditisMichael Schoppet, Sabine Pankuweit, Bernhard Maisch
Archives of Pathology & Laboratory Medicine|August 30, 2003
Cardiac sarcoidosis: cytokine patterns in the course of the diseaseMichael Schoppet, Sabine Pankuweit, Bernhard Maisch
The New England Journal of Medicine|April 22, 2011
NT5E mutations and arterial calcificationsLorenz C Hofbauer, Christine Hamann, Michael Schoppet
The New England Journal of Medicine|September 25, 2007
Estrogen therapy and coronary-artery calcificationLorenz C Hofbauer, Sundeep Khosla, Michael Schoppet
The New England Journal of Medicine|April 10, 2004
DKK1 in multiple myelomaLorenz C Hofbauer, Andreas Neubauer, Michael Schoppet
Circulation|March 26, 2003
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in menMichael Schoppet, Juergen R Schaefer, Lorenz C Hofbauer
Human Pathology|July 23, 2003
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adultSteffen Lamparter, Michael Schoppet, Sabine Pankuweit, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|November 15, 2002
Osteoprotegerin deficiency and juvenile Paget's diseaseLorenz C Hofbauer, Michael Schoppet
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular diseaseLorenz C Hofbauer, Michael Schoppet
JAMA|July 29, 2004
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseasesLorenz C Hofbauer, Michael Schoppet
Archives of Pathology & Laboratory Medicine|January 11, 2003
CD83+ dendritic cells in inflammatory infiltrates of Churg-Strauss myocarditisMichael Schoppet, Sabine Pankuweit, Bernhard Maisch
Archives of Pathology & Laboratory Medicine|August 30, 2003
Cardiac sarcoidosis: cytokine patterns in the course of the diseaseMichael Schoppet, Sabine Pankuweit, Bernhard Maisch
The New England Journal of Medicine|April 22, 2011
NT5E mutations and arterial calcificationsLorenz C Hofbauer, Christine Hamann, Michael Schoppet
The New England Journal of Medicine|September 25, 2007
Estrogen therapy and coronary-artery calcificationLorenz C Hofbauer, Sundeep Khosla, Michael Schoppet
The New England Journal of Medicine|April 10, 2004
DKK1 in multiple myelomaLorenz C Hofbauer, Andreas Neubauer, Michael Schoppet
Circulation|March 26, 2003
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in menMichael Schoppet, Juergen R Schaefer, Lorenz C Hofbauer
Human Pathology|July 23, 2003
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adultSteffen Lamparter, Michael Schoppet, Sabine Pankuweit, et al.
Pageof 5